{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "R",
          "position": "418"
        },
        "variant_string_id": "PARK2 C418R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is involved in the cellular homeostasis of a series of proteins by modulating their ubiquitylation and thereby controlling their subsequent degradation by the proteasome. Mutations in parkin are associated with autosomal recessive juvenile forms of Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, linking parkin mutations to Parkinson's disease through impaired protein degradation and transcriptional repression of p53."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses caspase-3 activity measurements, western blot analyses, p53 activity and promoter transactivation assays, and chromatin immunoprecipitation assays to assess the functional impact of parkin mutations.",
          "judgment": "Yes",
          "reasoning": "The general class of assays used effectively models the disease pathogenesis/mechanism, focusing on p53 transcriptional repression and apoptosis modulation, which are relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of controls (wild-type and mutant parkin) and replicates (n=3-10 independent experiments) in the assays.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were included, meeting the criteria for validity.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study uses known pathogenic variants (C418R, C441R, K161N, R256C) as controls to assess the impact on p53 transcriptional repression.",
          "judgment": "Yes",
          "reasoning": "Variant controls were used, including known pathogenic variants, which strengthens the validity of the assay.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses (P <0.05, P <0.01, P <0.001) were performed to assess the significance of the findings.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses were sufficient to estimate the pathogenicity likelihood from the functional data.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The study shows significant reductions in p53 expression and activity (P <0.001) for wild-type parkin compared to mutants, indicating a strong effect size.",
          "judgment": "Yes",
          "reasoning": "The statistical significance and effect size suggest a high OddsPath, supporting a pathogenic classification.",
          "next_step_or_outcome": "Assign PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The C418R mutation in PARK2 abolishes the parkin-mediated control of p53, as demonstrated by multiple functional assays with robust statistical significance, supporting a very strong pathogenic evidence strength (PS3_very_strong)."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "R",
          "position": "441"
        },
        "variant_string_id": "PARK2 C441R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin mutations impair its function as a transcriptional repressor of p53, contributing to Parkinson's disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is well-defined, linking parkin's transcriptional repression function to Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Assays include caspase-3 activity, p53 expression, and promoter transactivation, relevant to parkin's role in apoptosis and p53 regulation.",
          "judgment": "Yes",
          "reasoning": "The assays effectively model the disease mechanism, focusing on p53 regulation and apoptosis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls and replicates were used, with statistical significance reported (P <0.05 to P <0.001).",
          "judgment": "Yes",
          "reasoning": "The assays included necessary controls and replicates, meeting validity criteria.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic variants were used as controls to assess the impact on p53 transcriptional repression.",
          "judgment": "Yes",
          "reasoning": "The use of variant controls strengthens the assay's validity.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses showed significant differences in p53 expression and activity between wild-type and mutant parkin.",
          "judgment": "Yes",
          "reasoning": "The statistical analyses support a pathogenic interpretation.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "Significant reductions in p53 expression and activity (P <0.001) for wild-type parkin compared to mutants indicate a strong effect size.",
          "judgment": "Yes",
          "reasoning": "The data suggest a high OddsPath, supporting a pathogenic classification.",
          "next_step_or_outcome": "Assign PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The C441R mutation in PARK2 significantly impairs p53 transcriptional repression, with robust statistical evidence supporting a very strong pathogenic evidence strength (PS3_very_strong)."
    }
  ]
}